Roche Holding AG Dividend Right Cert. (CHF)
ROG
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
IndustryDrug Manufacturers - Major
Day Range286.75 | 290.10
52-Wk Range229.20 | 294.00
Last Close288.95
Mkt Cap (m)247,078.90
Dividend yield3.01%
ISINCH0012032048
Volume1,520,786
Exchange VenueSWX

Company Profile

Roche Holding AG is a pharmaceutical and diagnostic company. It specializes in medicines for oncology, virology, inflammation, metabolism, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology.

Key Information
Price/Earning21.11
Price/Book8.82
Price/Sales4.21
P/CF12.43
Rev Growth (3 year avg)5.69
EPS Growth (3 year avg)0.06
Operating Margin % 25.98
Net Margin %18.47
Return on Equity38.84
Debt/Equity0.68

Legal Documents

Annual Report
en 31/12/2018

Financials

Income Statement
CHF201320142015201620172018
Revenue (m)46,78047,46248,14550,57653,29956,846
Operating Income (m)16,37614,09013,82114,06913,00314,769
Net Income (m)11,1649,3328,8639,5768,63310,500
Basic EPS13.1610.9910.4211.2410.1212.29
Avg. Diluted Shares Outstanding (m)863863862860860860
Balance Sheet
CHF201320142015201620172018
Current Assets (m)29,16431,11428,18228,67031,57232,244
Non Current Assets (m)33,00344,52747,58148,14945,10446,273
Total Assets (m)62,16775,64175,76376,81976,67678,517
Current Liabilities (m)15,76023,10823,76822,60022,16023,033
Total Liabilities (m)------
Total Equity (m)19,29419,58620,97923,91126,44127,622
Cash Flows
CHF201320142015201620172018
Operating Cash Flows (m)15,77215,93015,25115,00118,02419,979
Capital Expenditure (m)-2,854-3,334-4,110-5,145-4,213-4,922
Figures are quoted in CHF unless stated otherwise
0.05 (0.02%)
289.00
Last Price